arrow
S

Soonmyung Paik

yonsei university health system
H指数:76
被引数:6.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression
2024-12-031
PRE
Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery
2024-09-100
PRE
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial
2023-05-252
OAAI
Association of stromal tumor infiltrating lymphocytes (sTILs) in pretreatment biopsies in different molecular subtypes of HER2+/ER+ breast cancer: Assessment of NRG Oncology/NSABP B-52
2023-03-010
PRE
Results from a phase III randomized, placebo-controlled clinical trial evaluating adjuvant endocrine therapy +/-1 year of everolimus in patients with high-risk hormone receptor-positive, HER2-negative breast cancer: SWOG S1207
2023-03-010
PRE
Assessment of estrogen receptor (ESR1) mRNA expression for prediction of extended aromatase inhibitor benefit in HR-positive breast cancer using NRG Oncology/NSABP B-42
2022-02-150
PRE
Dynamic changes in circulating PD-1+CD8+T lymphocytes for predicting treatment response to PD-1 blockade in patients with non-small-cell lung cancer

循环PD-1 CD8 T淋巴细胞的动态变化预测非小细胞肺癌患者对PD-1阻断的治疗反应

2021-01-0137
PREAI
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

小鼠-人类联合临床试验证明了buparlisib (BKM120) 和西妥昔单抗联合治疗头颈部鳞状细胞癌的优异抗肿瘤作用

2020-09-2322
OAAI
Peripheral natural killer cells and myeloid-derived suppressor cells correlate with anti-PD-1 responses in non-small cell lung cancer
2020-06-0345
OAAI